Astrotech Corporation ASTC Q1 2024 Earnings Net Loss Deepens as Company Focuses on Technology Commercialization Perspective Therapeutics Inc CATX Q1 2026 Earnings Loss Narrows Sharply Stock Gains 284 SNDR Q1 2026 Earnings EPS Beat with 1788 Surprise Amid Mixed Market Sentiment C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage OXLCN Q4 2025 Earnings Preferred Stock Reports Slight EPS Miss Amid Steady Portfolio Performance NVTS Q1 2026 Earnings Narrowed Loss Surpasses Estimates Shares Rally Nearly 20